Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 23 entries
Sorted by: Best Match Show Resources per page
Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers.

Hepatitis monthly

Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM.
PMID: 26977171
Hepat Mon. 2015 Dec 29;15(12):e35238. doi: 10.5812/hepatmon.35238. eCollection 2015 Dec.

CONTEXT: Hepatitis A virus (HAV) infection is an important public health problem. It is estimated that about 1.4 million cases of HAV infection occur every year worldwide. Non-immune healthcare workers (HCWs) can be at higher risk of HAV infection...

Cite
Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, et al. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015;15(12):e35238doi: 10.5812/hepatmon.35238.
Rezaee-Zavareh, M. S., Karimi-Sari, H., Dolatimehr, F., & Alavian, S. M. (2015). Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepatitis monthly, 15(12), e35238. https://doi.org/10.5812/hepatmon.35238
Rezaee-Zavareh, Mohammad Saeid, et al. "Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers." Hepatitis monthly vol. 15,12 (2015): e35238. doi: https://doi.org/10.5812/hepatmon.35238
Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepat Mon. 2015 Dec 29;15(12):e35238. doi: 10.5812/hepatmon.35238. eCollection 2015 Dec. PMID: 26977171; PMCID: PMC4779254.
Copy Download .nbib Format: NLM
Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax.

Iranian Red Crescent medical journal

Afsharpaiman S, Rezaee Zavareh MS, Torkaman M.
PMID: 26568847
Iran Red Crescent Med J. 2015 Oct 13;17(10):e18915. doi: 10.5812/ircmj.18915. eCollection 2015 Oct.

INTRODUCTION: A rare condition in newborns called congenital chylothorax (CC) occurs when lymphatic fluid accumulates within the pleural cavity. Here is a presentation of a birth traumatic case with bilateral pleural effusion successfully treated by octreotide.CASE PRESENTATION: A 3100-g-term...

Cite
Afsharpaiman S, Rezaee Zavareh MS, Torkaman M. Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax. Iran Red Crescent Med J. 2015;17(10):e18915doi: 10.5812/ircmj.18915.
Afsharpaiman, S., Rezaee Zavareh, M. S., & Torkaman, M. (2015). Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax. Iranian Red Crescent medical journal, 17(10), e18915. https://doi.org/10.5812/ircmj.18915
Afsharpaiman, Shahla, et al. "Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax." Iranian Red Crescent medical journal vol. 17,10 (2015): e18915. doi: https://doi.org/10.5812/ircmj.18915
Afsharpaiman S, Rezaee Zavareh MS, Torkaman M. Low Dose of Octreotide Can be Helpful in the Management of Congenital Chylothorax. Iran Red Crescent Med J. 2015 Oct 13;17(10):e18915. doi: 10.5812/ircmj.18915. eCollection 2015 Oct. PMID: 26568847; PMCID: PMC4636752.
Copy Download .nbib Format: NLM
Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival.

International journal of organ transplantation medicine

Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, Heydari F, Einollahi B.
PMID: 26306157
Int J Organ Transplant Med. 2015;6(3):114-8.

BACKGROUND: It is said that renal transplantation lithiasis is rare. However, literature has some different frequencies in this field and most of the studies related to this issue are case reports. Also the exact effect of this complication on...

Cite
Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, et al. Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival. Int J Organ Transplant Med. 2015;6(3):114-8
Rezaee-Zavareh, M. S., Ajudani, R., Ramezani Binabaj, M., Heydari, F., & Einollahi, B. (2015). Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival. International journal of organ transplantation medicine, 6(3), 114-8.
Rezaee-Zavareh, M S, et al. "Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival." International journal of organ transplantation medicine vol. 6,3 (2015): 114-8.
Rezaee-Zavareh MS, Ajudani R, Ramezani Binabaj M, Heydari F, Einollahi B. Kidney Allograft Stone after Kidney Transplantation and its Association with Graft Survival. Int J Organ Transplant Med. 2015;6(3):114-8. PMID: 26306157; PMCID: PMC4545305.
Copy Download .nbib Format: NLM
How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals?.

Iranian journal of public health

Reaee-Zavareh MS, Karimi-Sari H.
PMID: 33083305
Iran J Public Health. 2020 Jul;49(7):1372-1375. doi: 10.18502/ijph.v49i7.3592.

No abstract available.

Cite
Reaee-Zavareh MS, Karimi-Sari H. How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals?. Iran J Public Health. 2020;49(7):1372-1375doi: 10.18502/ijph.v49i7.3592.
Reaee-Zavareh, M. S., & Karimi-Sari, H. (2020). How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals?. Iranian journal of public health, 49(7), 1372-1375. https://doi.org/10.18502/ijph.v49i7.3592
Reaee-Zavareh, Mohammad Saeid, and Karimi-Sari, Hamidreza. "How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals?." Iranian journal of public health vol. 49,7 (2020): 1372-1375. doi: https://doi.org/10.18502/ijph.v49i7.3592
Reaee-Zavareh MS, Karimi-Sari H. How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals?. Iran J Public Health. 2020 Jul;49(7):1372-1375. doi: 10.18502/ijph.v49i7.3592. PMID: 33083305; PMCID: PMC7548492.
Copy Download .nbib Format: NLM
Creating a culture of ethics in Iran.

Science (New York, N.Y.)

Rezaee-Zavareh MS, Naji Z, Salamati P.
PMID: 27846525
Science. 2016 Oct 21;354(6310):296. doi: 10.1126/science.aal0019.

No abstract available.

Cite
Rezaee-Zavareh MS, Naji Z, Salamati P. Creating a culture of ethics in Iran. Science. 2016;354(6310):296doi: 10.1126/science.aal0019.
Rezaee-Zavareh, M. S., Naji, Z., & Salamati, P. (2016). Creating a culture of ethics in Iran. Science (New York, N.Y.), 354(6310), 296. https://doi.org/10.1126/science.aal0019
Rezaee-Zavareh, Mohammad Saeid, et al. "Creating a culture of ethics in Iran." Science (New York, N.Y.) vol. 354,6310 (2016): 296. doi: https://doi.org/10.1126/science.aal0019
Rezaee-Zavareh MS, Naji Z, Salamati P. Creating a culture of ethics in Iran. Science. 2016 Oct 21;354(6310):296. doi: 10.1126/science.aal0019. PMID: 27846525.
Copy Download .nbib Format: NLM
Infectious and coronary artery disease.

ARYA atherosclerosis

Rezaee-Zavareh MS, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M, Einollahi B.
PMID: 27114736
ARYA Atheroscler. 2016 Jan;12(1):41-9.

BACKGROUND: Atherosclerotic event is one of the most causes of death in the world. Coronary artery disease (CAD) is one manifestation of atherosclerosis. It is well-known that several risk factors, such as diabetes mellitus (DM), smoking, hypertension (HTN), have...

Cite
Rezaee-Zavareh MS, Tohidi M, Sabouri A, et al. Infectious and coronary artery disease. ARYA Atheroscler. 2016;12(1):41-9
Rezaee-Zavareh, M. S., Tohidi, M., Sabouri, A., Ramezani-Binabaj, M., Sadeghi-Ghahrodi, M., & Einollahi, B. (2016). Infectious and coronary artery disease. ARYA atherosclerosis, 12(1), 41-9.
Rezaee-Zavareh, Mohammad Saeid, et al. "Infectious and coronary artery disease." ARYA atherosclerosis vol. 12,1 (2016): 41-9.
Rezaee-Zavareh MS, Tohidi M, Sabouri A, Ramezani-Binabaj M, Sadeghi-Ghahrodi M, Einollahi B. Infectious and coronary artery disease. ARYA Atheroscler. 2016 Jan;12(1):41-9. PMID: 27114736; PMCID: PMC4834180.
Copy Download .nbib Format: NLM
Hepatitis Monthly, an International Journal in the Field of Hepatology.

Hepatitis monthly

Rezaee-Zavareh MS, Sa'adat SH, Alavian SM.
PMID: 27226805
Hepat Mon. 2016 Mar 12;16(3):e37015. doi: 10.5812/hepatmon.37015. eCollection 2016 Mar.

No abstract available.

Cite
Rezaee-Zavareh MS, Sa'adat SH, Alavian SM. Hepatitis Monthly, an International Journal in the Field of Hepatology. Hepat Mon. 2016;16(3):e37015doi: 10.5812/hepatmon.37015.
Rezaee-Zavareh, M. S., Sa'adat, S. H., & Alavian, S. M. (2016). Hepatitis Monthly, an International Journal in the Field of Hepatology. Hepatitis monthly, 16(3), e37015. https://doi.org/10.5812/hepatmon.37015
Rezaee-Zavareh, Mohammad Saeid, et al. "Hepatitis Monthly, an International Journal in the Field of Hepatology." Hepatitis monthly vol. 16,3 (2016): e37015. doi: https://doi.org/10.5812/hepatmon.37015
Rezaee-Zavareh MS, Sa'adat SH, Alavian SM. Hepatitis Monthly, an International Journal in the Field of Hepatology. Hepat Mon. 2016 Mar 12;16(3):e37015. doi: 10.5812/hepatmon.37015. eCollection 2016 Mar. PMID: 27226805; PMCID: PMC4875567.
Copy Download .nbib Format: NLM
Treatment of occult hepatitis C virus infection: does it need special attention?.

Hepatitis monthly

Rezaee-Zavareh MS, Einollahi B.
PMID: 25067939
Hepat Mon. 2014 Jul 01;14(7):e16665. doi: 10.5812/hepatmon.16665. eCollection 2014 Jul.

No abstract available.

Cite
Rezaee-Zavareh MS, Einollahi B. Treatment of occult hepatitis C virus infection: does it need special attention?. Hepat Mon. 2014;14(7):e16665doi: 10.5812/hepatmon.16665.
Rezaee-Zavareh, M. S., & Einollahi, B. (2014). Treatment of occult hepatitis C virus infection: does it need special attention?. Hepatitis monthly, 14(7), e16665. https://doi.org/10.5812/hepatmon.16665
Rezaee-Zavareh, Mohammad Saeid, and Einollahi, Behzad. "Treatment of occult hepatitis C virus infection: does it need special attention?." Hepatitis monthly vol. 14,7 (2014): e16665. doi: https://doi.org/10.5812/hepatmon.16665
Rezaee-Zavareh MS, Einollahi B. Treatment of occult hepatitis C virus infection: does it need special attention?. Hepat Mon. 2014 Jul 01;14(7):e16665. doi: 10.5812/hepatmon.16665. eCollection 2014 Jul. PMID: 25067939; PMCID: PMC4101422.
Copy Download .nbib Format: NLM
Occult HCV Infection: The Current State of Knowledge.

Iranian Red Crescent medical journal

Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Hossein Khosravi M, Ajudani R, Dolatimehr F, Ramezani-Binabaj M, Miri SM, Alavian SM.
PMID: 26734487
Iran Red Crescent Med J. 2015 Nov 29;17(11):e34181. doi: 10.5812/ircmj.34181. eCollection 2015 Nov.

CONTEXT: Occult HCV infection (OCI) is defined as the presence of HCV-RNA in hepatocytes and the absence of HCV in the serum according to usual tests. We aimed to define OCI and provide information about the currently available diagnostic...

Cite
Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, et al. Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J. 2015;17(11):e34181doi: 10.5812/ircmj.34181.
Rezaee-Zavareh, M. S., Hadi, R., Karimi-Sari, H., Hossein Khosravi, M., Ajudani, R., Dolatimehr, F., Ramezani-Binabaj, M., Miri, S. M., & Alavian, S. M. (2015). Occult HCV Infection: The Current State of Knowledge. Iranian Red Crescent medical journal, 17(11), e34181. https://doi.org/10.5812/ircmj.34181
Rezaee-Zavareh, Mohammad Saeid, et al. "Occult HCV Infection: The Current State of Knowledge." Iranian Red Crescent medical journal vol. 17,11 (2015): e34181. doi: https://doi.org/10.5812/ircmj.34181
Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Hossein Khosravi M, Ajudani R, Dolatimehr F, Ramezani-Binabaj M, Miri SM, Alavian SM. Occult HCV Infection: The Current State of Knowledge. Iran Red Crescent Med J. 2015 Nov 29;17(11):e34181. doi: 10.5812/ircmj.34181. eCollection 2015 Nov. PMID: 26734487; PMCID: PMC4698335.
Copy Download .nbib Format: NLM
Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies.

Hepatitis monthly

Rezaee Zavareh MS, Alavian SM.
PMID: 26834794
Hepat Mon. 2015 Nov 28;15(11):e33462. doi: 10.5812/hepatmon.33462. eCollection 2015 Nov.

No abstract available.

Cite
Rezaee Zavareh MS, Alavian SM. Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies. Hepat Mon. 2015;15(11):e33462doi: 10.5812/hepatmon.33462.
Rezaee Zavareh, M. S., & Alavian, S. M. (2015). Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies. Hepatitis monthly, 15(11), e33462. https://doi.org/10.5812/hepatmon.33462
Rezaee Zavareh, Mohammad Saeid, and Alavian, Seyed Moayed. "Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies." Hepatitis monthly vol. 15,11 (2015): e33462. doi: https://doi.org/10.5812/hepatmon.33462
Rezaee Zavareh MS, Alavian SM. Occult Hepatitis C Infection Should Be More Noticed With New Treatment Strategies. Hepat Mon. 2015 Nov 28;15(11):e33462. doi: 10.5812/hepatmon.33462. eCollection 2015 Nov. PMID: 26834794; PMCID: PMC4717287.
Copy Download .nbib Format: NLM
Seroprevalence of hepatitis A virus among Iranian soldiers.

Gastroenterology and hepatology from bed to bench

Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS.
PMID: 27099669
Gastroenterol Hepatol Bed Bench. 2016;9(2):100-4.

AIM: This study aims to investigate the seroprevalence of HAV immunity among Iranian soldiers and determine whether vaccination should be given to military draftees.BACKGROUND: Hepatitis A virus (HAV) is highly contagious in individuals living in crowded conditions such as...

Cite
Izadi M, Esfahani AA, Hassannia H, et al. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016;9(2):100-4
Izadi, M., Esfahani, A. A., Hassannia, H., Jonaidi Jafari, N., Rahmati Najarkolaei, F., & Rezaee-Zavareh, M. S. (2016). Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterology and hepatology from bed to bench, 9(2), 100-4.
Izadi, Morteza, et al. "Seroprevalence of hepatitis A virus among Iranian soldiers." Gastroenterology and hepatology from bed to bench vol. 9,2 (2016): 100-4.
Izadi M, Esfahani AA, Hassannia H, Jonaidi Jafari N, Rahmati Najarkolaei F, Rezaee-Zavareh MS. Seroprevalence of hepatitis A virus among Iranian soldiers. Gastroenterol Hepatol Bed Bench. 2016;9(2):100-4. PMID: 27099669; PMCID: PMC4833848.
Copy Download .nbib Format: NLM
Control or placebo group in a clinical trial.

International journal of preventive medicine

Rezaee-Zavareh MS.
PMID: 25830008
Int J Prev Med. 2015 Mar 03;6:19. doi: 10.4103/2008-7802.152495. eCollection 2015.

No abstract available.

Cite
Rezaee-Zavareh MS. Control or placebo group in a clinical trial. Int J Prev Med. 2015;6:19doi: 10.4103/2008-7802.152495.
Rezaee-Zavareh, M. S. (2015). Control or placebo group in a clinical trial. International journal of preventive medicine, 619. https://doi.org/10.4103/2008-7802.152495
Rezaee-Zavareh, Mohammad Saeid. "Control or placebo group in a clinical trial." International journal of preventive medicine vol. 6 (2015): 19. doi: https://doi.org/10.4103/2008-7802.152495
Rezaee-Zavareh MS. Control or placebo group in a clinical trial. Int J Prev Med. 2015 Mar 03;6:19. doi: 10.4103/2008-7802.152495. eCollection 2015. PMID: 25830008; PMCID: PMC4378032.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 23 entries